Prognostic Effect of Body Composition in Cancer Survivors

The Impact of DXA-Based Body Composition Phenotypes on the All-cause Mortality Among the US Cancer Survivors

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06398782

Enrollment

1500

Registered

2024-05-03

Start date

1999-01-01

Completion date

2018-12-31

Last updated

2024-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Composition, Morality, Cancer Survivor

Brief summary

This study aims to evaluate the association between body composition and mortality risk among the US population based on data from the National Health and Nutrition Examination Survey (NHANES), a nationally representative cohort.

Interventions

DEVICEbody composition assessment

body composition of cancer survivors were assessed by Dual-energy X-ray absorptiometry

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Participants with cancer diagnosis beyond 18 years old.

Exclusion criteria

* Participants with missing cancer investigations and incomplete DXA body composition data were excluded from the study.

Design outcomes

Primary

Measure	Time frame	Description
Rate of all-cause mortality	Jan 1 1999 to Dec 31 2019	To evaluate the association between fat mass index (FMI, fat mass and height will be combined to report FMI in kg/m\^2) and all-cause mortality among cancer survivors.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026